Northrop Grumman Corporation vs Regeneron Pharmaceuticals, Inc.
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก ๋น๊ต
Northrop Grumman Corporation
$81.0B
์์ #196
Regeneron Pharmaceuticals, Inc.
$81.5B
์์ #193
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก
์ฃผ์ ์๊ฐ
- Regeneron Pharmaceuticals, Inc.์ด(๊ฐ) 2000๋ ๊น์ง Northrop Grumman Corporation์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- Northrop Grumman Corporation์ด(๊ฐ) 2001๋ ๊น์ง Regeneron Pharmaceuticals, Inc.์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- Regeneron Pharmaceuticals, Inc.์ด(๊ฐ) 2012๋ ๊น์ง Northrop Grumman Corporation์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- Northrop Grumman Corporation์ด(๊ฐ) 2019๋ ๊น์ง Regeneron Pharmaceuticals, Inc.์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- Regeneron Pharmaceuticals, Inc.์ด(๊ฐ) 2020๋ ๊น์ง Northrop Grumman Corporation์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- Northrop Grumman Corporation์ด(๊ฐ) 2025๋ ๊น์ง Regeneron Pharmaceuticals, Inc.์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- Regeneron Pharmaceuticals, Inc.์ด(๊ฐ) 2026๋ ๊น์ง Northrop Grumman Corporation์(๋ฅผ) ์ถ์ํ์ต๋๋ค
์ฐ๋๋ณ ๋น๊ต
| ์ฐ๋ | Northrop Grumman Corporation | Regeneron Pharmaceuticals, Inc. | ์ ๋ |
|---|---|---|---|
| 2026 | $81.0B | $81.5B | Regeneron Pharmaceuticals, Inc. |
| 2025 | $80.1B | $79.3B | Northrop Grumman Corporation |
| 2024 | $64.7B | $72.8B | Regeneron Pharmaceuticals, Inc. |
| 2023 | $63.8B | $89.7B | Regeneron Pharmaceuticals, Inc. |
| 2022 | $73.1B | $73.7B | Regeneron Pharmaceuticals, Inc. |
| 2021 | $51.1B | $64.5B | Regeneron Pharmaceuticals, Inc. |
| 2020 | $39.6B | $49.4B | Regeneron Pharmaceuticals, Inc. |
| 2019 | $43.9B | $38.4B | Northrop Grumman Corporation |
| 2018 | $30.8B | $38.2B | Regeneron Pharmaceuticals, Inc. |
| 2017 | $37.8B | $38.4B | Regeneron Pharmaceuticals, Inc. |
| 2016 | $28.3B | $37.5B | Regeneron Pharmaceuticals, Inc. |
| 2015 | $22.7B | $55.5B | Regeneron Pharmaceuticals, Inc. |
| 2014 | $17.4B | $41.9B | Regeneron Pharmaceuticals, Inc. |
| 2013 | $13.2B | $28.1B | Regeneron Pharmaceuticals, Inc. |
| 2012 | $7.6B | $17.5B | Regeneron Pharmaceuticals, Inc. |
| 2011 | $6.3B | $5.7B | Northrop Grumman Corporation |
| 2010 | $6.1B | $3.4B | Northrop Grumman Corporation |
| 2009 | $5.1B | $2.5B | Northrop Grumman Corporation |
| 2008 | $4.0B | $1.9B | Northrop Grumman Corporation |
| 2007 | $6.8B | $2.5B | Northrop Grumman Corporation |
| 2006 | $5.7B | $2.1B | Northrop Grumman Corporation |
| 2005 | $5.0B | $1.6B | Northrop Grumman Corporation |
| 2004 | $4.4B | $941.1M | Northrop Grumman Corporation |
| 2003 | $3.8B | $1.5B | Northrop Grumman Corporation |
| 2002 | $3.8B | $1.9B | Northrop Grumman Corporation |
| 2001 | $3.9B | $2.9B | Northrop Grumman Corporation |
| 2000 | $3.2B | $3.6B | Regeneron Pharmaceuticals, Inc. |
| 1999 | $2.0B | $1.3B | Northrop Grumman Corporation |
| 1998 | $2.7B | $753.6M | Northrop Grumman Corporation |
| 1997 | $4.1B | $874.9M | Northrop Grumman Corporation |
| 1996 | $2.9B | $1.6B | Northrop Grumman Corporation |
| 1995 | $2.2B | $1.3B | Northrop Grumman Corporation |
| 1994 | $1.4B | $306.5M | Northrop Grumman Corporation |